These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
44. Circulating microRNAs in heart failure with reduced and preserved left ventricular ejection fraction. Wong LL; Armugam A; Sepramaniam S; Karolina DS; Lim KY; Lim JY; Chong JP; Ng JY; Chen YT; Chan MM; Chen Z; Yeo PS; Ng TP; Ling LH; Sim D; Leong KT; Ong HY; Jaufeerally F; Wong R; Chai P; Low AF; Lam CS; Jeyaseelan K; Richards AM Eur J Heart Fail; 2015 Apr; 17(4):393-404. PubMed ID: 25619197 [TBL] [Abstract][Full Text] [Related]
45. New echocardiographic predictors of clinical outcome in patients presenting with heart failure and a preserved left ventricular ejection fraction: a subanalysis of the Ka (Karolinska) Ren (Rennes) Study. Donal E; Lund LH; Oger E; Hage C; Persson H; Reynaud A; Ennezat PV; Bauer F; Drouet E; Linde C; Daubert C; Eur J Heart Fail; 2015 Jul; 17(7):680-8. PubMed ID: 26033771 [TBL] [Abstract][Full Text] [Related]
46. Longitudinal, circumferential and radial systolic left ventricular function in patients with heart failure and preserved ejection fraction. Gregorova Z; Meluzin J; Stepanova R; Sitar J; Podrouzkova H; Spinarova L Biomed Pap Med Fac Univ Palacky Olomouc Czech Repub; 2016 Sep; 160(3):385-92. PubMed ID: 26948032 [TBL] [Abstract][Full Text] [Related]
47. Use of Inflammatory Biomarkers and Real-Time Cardiac Catheterisation to Evaluate the Left Ventricular Diastolic Function in Patients With Diastolic Heart Failure. Xu L; Yan J; Zhang F; Zhou C; Fan T; Chen X; Cui X; Zhou H; Liang Y Heart Lung Circ; 2021 Mar; 30(3):396-403. PubMed ID: 32736962 [TBL] [Abstract][Full Text] [Related]
48. [Changes in serum insulin-like growth factor-1 and insulin-like growth factor-binding protein-3, and their significance in children with left-to-right shunt congenital heart disease associated with heart failure]. Peng J; Fu J; Deng SZ; Wang RG; Liu L; Sun DM; Xia K Zhongguo Dang Dai Er Ke Za Zhi; 2013 Apr; 15(4):277-80. PubMed ID: 23607950 [TBL] [Abstract][Full Text] [Related]
49. Right ventricular function in heart failure with preserved ejection fraction: a community-based study. Mohammed SF; Hussain I; AbouEzzeddine OF; Takahama H; Kwon SH; Forfia P; Roger VL; Redfield MM Circulation; 2014 Dec; 130(25):2310-20. PubMed ID: 25391518 [TBL] [Abstract][Full Text] [Related]
50. Analysis of circumferential and longitudinal left ventricular systolic function in patients with non-ischemic chronic heart failure and preserved ejection fraction (from the CARRY-IN-HFpEF study). Cioffi G; Senni M; Tarantini L; Faggiano P; Rossi A; Stefenelli C; Russo TE; Alessandro S; Furlanello F; de Simone G Am J Cardiol; 2012 Feb; 109(3):383-9. PubMed ID: 22112740 [TBL] [Abstract][Full Text] [Related]
51. Effects of spironolactone treatment in elderly women with heart failure and preserved left ventricular ejection fraction. Kurrelmeyer KM; Ashton Y; Xu J; Nagueh SF; Torre-Amione G; Deswal A J Card Fail; 2014 Aug; 20(8):560-8. PubMed ID: 24905296 [TBL] [Abstract][Full Text] [Related]
52. The HFA-PEFF score identifies 'early-HFpEF' phenogroups associated with distinct biomarker profiles. Henkens MTHM; van Ommen AM; Remmelzwaal S; Valstar GB; Wang P; Verdonschot JAJ; Hazebroek MR; Hofstra L; van Empel VPM; Beulens JWJ; den Ruijter HM; Heymans SRB ESC Heart Fail; 2022 Jun; 9(3):2032-2036. PubMed ID: 35301820 [TBL] [Abstract][Full Text] [Related]
53. Cardiovascular features of heart failure with preserved ejection fraction versus nonfailing hypertensive left ventricular hypertrophy in the urban Baltimore community: the role of atrial remodeling/dysfunction. Melenovsky V; Borlaug BA; Rosen B; Hay I; Ferruci L; Morell CH; Lakatta EG; Najjar SS; Kass DA J Am Coll Cardiol; 2007 Jan; 49(2):198-207. PubMed ID: 17222731 [TBL] [Abstract][Full Text] [Related]
54. Increased left atrial volume index is an independent predictor of raised serum natriuretic peptide in patients with suspected heart failure but normal left ventricular ejection fraction: Implication for diagnosis of diastolic heart failure. Lim TK; Ashrafian H; Dwivedi G; Collinson PO; Senior R Eur J Heart Fail; 2006 Jan; 8(1):38-45. PubMed ID: 16115798 [TBL] [Abstract][Full Text] [Related]
55. The insulin-like growth factor and binding protein axis in children with end-stage liver disease before and after orthotopic liver transplantation. Holt RI; Baker AJ; Jones JS; Miell JP Pediatr Transplant; 1998 Feb; 2(1):76-84. PubMed ID: 10084765 [TBL] [Abstract][Full Text] [Related]
56. Echocardiographic parameters differentiating heart failure with preserved ejection fraction from asymptomatic left ventricular diastolic dysfunction. Ibrahim IM; Hafez H; Al-Shair MHA; El Zayat A Echocardiography; 2020 Feb; 37(2):247-252. PubMed ID: 31944376 [TBL] [Abstract][Full Text] [Related]
57. Insulin-like growth factor (IGF)-I, IGF-II and IGF-binding protein (IGFBP)-3 levels in Arab subjects with coronary heart disease. Akanji AO; Suresh CG; Al-Radwan R; Fatania HR Scand J Clin Lab Invest; 2007; 67(5):553-9. PubMed ID: 17763192 [TBL] [Abstract][Full Text] [Related]
58. Differential impact of heart rate and blood pressure on outcome in patients with heart failure with reduced versus preserved left ventricular ejection fraction. Maeder MT; Kaye DM Int J Cardiol; 2012 Mar; 155(2):249-56. PubMed ID: 21035207 [TBL] [Abstract][Full Text] [Related]
59. Left atrial remodeling and function in advanced heart failure with preserved or reduced ejection fraction. Melenovsky V; Hwang SJ; Redfield MM; Zakeri R; Lin G; Borlaug BA Circ Heart Fail; 2015 Mar; 8(2):295-303. PubMed ID: 25593126 [TBL] [Abstract][Full Text] [Related]
60. IGFBP7 (Insulin-Like Growth Factor-Binding Protein-7) and Neprilysin Inhibition in Patients With Heart Failure. Januzzi JL; Packer M; Claggett B; Liu J; Shah AM; Zile MR; Pieske B; Voors A; Gandhi PU; Prescott MF; Shi V; Lefkowitz MP; McMurray JJV; Solomon SD Circ Heart Fail; 2018 Oct; 11(10):e005133. PubMed ID: 30354399 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]